HIMS has experienced a significant decline over the past six months, down nearly 40%. Despite this bearish trend, analysts maintain a 'Buy' rating with a target price of $31.68. The stock is currently trading near its 52-week low, presenting a potential buying opportunity. While the company's free cash flow is projected to grow, concerns remain about its current valuation and past financial performance.